Howard Liang Insider Profile
4 Followers
Howard Liang, CFO & Chief Strategy Officer at BeOne Medicines, holds 1.55M shares in BeOne Medicines (Ticker: ONC). Most recently, Howard Liang Sold 446 shares of BeOne Medicines on Jun 30, 2021 for an estimated value of $162.79K.
Howard Liang's Trading History
| ONCBeOne Medicines | Jun 30, 2021 | CFO & Chief Strategy Officer | Informative Sell | 162.79K | $638.79M | |
ONC Insider Shares: 1.55M (1.68%) | ||||||
You May Also Like
Howard Liang insider profile FAQ
What is the percentage of profitable transactions made by Howard Liang?
The percentage of profitable transactions made by Howard Liang is 50%.
What is the average return per transaction made by Howard Liang?
The average return per transaction made by Howard Liang is -12.70%.
What stocks does Howard Liang hold?
Howard Liang holds: ONC stocks.
What was Howard Liang’s latest transaction?
Howard Liang’s latest transaction was an Informative Sell of $162.79K.
What was Howard Liang's most profitable transaction?
Howard Liang’s most profitable transaction was an Informative Sell of ONC stock on June 9, 2021. The return on the trade was 56.60%.
What is Howard Liang's role in BeOne Medicines?
Howard Liang's role in BeOne Medicines is CFO & Chief Strategy Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
